Table 7.

Prevalence of general side effects after the second dose of Sinopharm COVID-19 vaccination among 2 groups of participants (females vs males) (n 1080)

Side effect	Female (760)	Percent	Male (320)	Percent	Total (1080)	Percent	p-value
Normal pain at the vaccination site	264	34.7%	100	31.3%	352	32.6%	0.482
Severe pain at the vaccination site	80	10.5%	8	2.5%	88	8.1%	0.027
Tenderness	84	11%	24	7.5%	108	10%	0.368
Redness	12	1.6%	4	1.25%	16	1.5%	0.834
Induration and pruritus at the vaccination site	12	1.6%	0	0	12	1%	0.257
Fever	28	3.7%	4	1.25%	32	3%	0.279
Headache	80	10%	28	8.75%	108	10%	0.648
Fatigue	152	20%	24	7.5%	176	16.3%	0.011
Nausea	12	1.6%	0	0	12	1.1%	0.257
Diarrhea	8	1.1%	0	0	8	0.7%	0.356
Cough	8	1.1%	0	0	8	0.7%	0.356
Allergy	0	0	0	0	0	0	_
Muscle pain	52	6.8%	12	3.75%	64	6%	0.321
Abdominal pain	12	1.6%	4	1.25%	16	1.5%	0.834
Back pain	28	3.7%	4	1.25%	32	3%	0.279
Lethargy	124	16%	24	7.5%	148	13.7%	0.053
None	88	11.6%	64	20%	152	14.07%	0.072